Research & Literature

[Complications and outcomes in the elderly with intracranial meningioma].

Troya Castilla M, Chocrón Gonzalez Y, Márquez Rivas FJ

Revista espanola de geriatria y gerontologia 2016; (51(2)):82-7.

Systemic therapy for recurrent meningioma.

Le Rhun E, Taillibert S, Chamberlain MC

Expert review of neurotherapeutics 2016; (16(8)):889-901 doi:10.1080/14737175.2016.1184087.

EANO guidelines for the diagnosis and treatment of meningiomas.

Goldbrunner R, Minniti G, Preusser M, et al.

The Lancet. Oncology 2016; (17(9)):e383-91.

Falcine Meningiomas: Analysis of the Impact of Radiologic Tumor Extensions and Proposal of a Modified Preoperative Radiologic Classification Scheme.

Das KK, Gosal JS, Sharma P, et al.

World neurosurgery 2017; (104()):248-258 doi:10.1016/j.wneu.2017.04.159.

Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.

Orton A, Frandsen J, Jensen R, et al.

Journal of neurosurgery 2018; (128(6)):1684-1689.

The modified frailty index and 30-day adverse events in oncologic neurosurgery.

Youngerman BE, Neugut AI, Yang J, et al.

Journal of neuro-oncology 2018; (136(1)):197-206 doi:10.1007/s11060-017-2644-0.

Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas.

Menger R, Connor DE, Chan AY, et al.

Cureus 2017; (9(11)):e1820 doi:10.7759/cureus.1820.

Is Psychiatric Depression a Presenting Neurologic Sign of Meningioma? A Critical Review of the Literature with Causative Etiology.

Kessler RA, Loewenstern J, Kohli K, Shrivastava RK

World neurosurgery 2018; (112()):64-72 doi:10.1016/j.wneu.2018.01.074.

Preoperative verbal memory problems and their clinical prognostic value in meningioma patients: A prospective study.

Pranckevičienė A, Jurkuvėnas V, Deltuva VP, et al.

Applied neuropsychology. Adult 2019; (26(6)):503-512 doi:10.1080/23279095.2018.1450750.

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.

Spiegl-Kreinecker S, Lötsch D, Neumayer K, et al.

Neuro-oncology 2018; (20(12)):1584-1593 doi:10.1093/neuonc/noy104.

Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?

Dasanu CA, Samara Y, Codreanu I, et al.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2019; (25(3)):638-647 doi:10.1177/1078155218799850.

Distinguishing Falcine Chondrosarcomas from Their Mimics and Management.

Omezine S, Bouali S, Taallah M, et al.

World neurosurgery 2018; (118()):279-283 doi:10.1016/j.wneu.2018.06.164.

Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005-2015, using the Central Brain Tumor Registry of the United States.

Achey RL, Gittleman H, Schroer J, et al.

Neuro-oncology 2019; (21(3)):380-391 doi:10.1093/neuonc/noy162.

Can unenhanced brain magnetic resonance imaging be used in routine follow up of meningiomas to avoid gadolinium deposition in brain?

Rahatli FK, Donmez FY, Kesim C, et al.

Clinical imaging 2019; (53()):155-161 doi:10.1016/j.clinimag.2018.10.014.

Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.

Islim AI, Mohan M, Moon RDC, et al.

Journal of neuro-oncology 2019; (142(2)):211-221 doi:10.1007/s11060-019-03104-3.

Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma.

Supartoto A, Mahayana IT, Heriyanto DS, et al.

International journal of ophthalmology 2019; (12(4)):571-576 doi:10.18240/ijo.2019.04.07.

Challenging the concept that late recurrence and death from tumor are common after fractionated radiotherapy for benign meningioma.

O'steen L, Amdur RJ, Morris CG, Mendenhall WM

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2019; (137()):55-60 doi:10.1016/j.radonc.2019.04.017.

Predictive Factors for Seizures Accompanying Intracranial Meningiomas.

Morsy MM, El-Saadany WF, Moussa WM, Sultan AE

Asian journal of neurosurgery 2019; (14(2)):403-409 doi:10.4103/ajns.AJNS_152_18.

Clinical and Radiographic Features for Differentiating Solitary Fibrous Tumor/Hemangiopericytoma From Meningioma.

Ohba S, Murayama K, Nishiyama Y, et al.

World neurosurgery 2019; (130()):e383-e392 doi:10.1016/j.wneu.2019.06.094.

Elderly Patients with Intracranial Meningioma: Surgical Considerations in 228 Patients with a Comprehensive Analysis of the Literature.

Ekşi MŞ, Canbolat Ç, Akbaş A, et al.

World neurosurgery 2019; (132()):e350-e365 doi:10.1016/j.wneu.2019.08.150.

Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.

Lamba N, Hwang WL, Kim DW, et al.

World neurosurgery 2020; (133()):e804-e812 doi:10.1016/j.wneu.2019.10.002.

Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.

Chen T, Jiang B, Zheng Y, et al.

Neuroradiology 2020; (62(2)):175-184 doi:10.1007/s00234-019-02307-9.

A prospective study of the natural history of incidental meningioma-Hold your horses!

Behbahani M, Skeie GO, Eide GE, et al.

Neuro-oncology practice 2019; (6(6)):438-450 doi:10.1093/nop/npz011.

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.

Mirian C, Duun-Henriksen AK, Juratli T, et al.

Journal of neurology, neurosurgery, and psychiatry 2020; (91(4)):378-387 doi:10.1136/jnnp-2019-322257.

Stereotactic Radiosurgery for Intracranial Noncavernous Sinus Benign Meningioma: International Stereotactic Radiosurgery Society Systematic Review, Meta-Analysis and Practice Guideline.

Marchetti M, Sahgal A, De Salles AAF, et al.

Neurosurgery 2020; (87(5)):879-890 doi:10.1093/neuros/nyaa169.

Foramen magnum meningiomas.

Bir SC, Maiti TK, Nanda A

Handbook of clinical neurology 2020; (170()):167-174 doi:10.1016/B978-0-12-822198-3.00038-0.

The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients.

Khalafallah AM, Huq S, Jimenez AE, et al.

Journal of neurosurgery 2021; (135(1)):78-86 doi:10.3171/2020.5.JNS20766.

Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience.

Przybylowski CJ, Hendricks BK, Frisoli FA, et al.

Journal of neurosurgery 2021; (135(2)):515-523 doi:10.3171/2020.6.JNS20374.

A Practical Overview on the Molecular Biology of Meningioma.

Delgado-López PD, Cubo-Delgado E, González-Bernal JJ, Martín-Alonso J

Current neurology and neuroscience reports 2020; (20(12)):62 doi:10.1007/s11910-020-01084-w.

Dural-based lesions: is it a meningioma?

Nagai Yamaki V, de Souza Godoy LF, Alencar Bandeira G, et al.

Neuroradiology 2021; (63(8)):1215-1225 doi:10.1007/s00234-021-02632-y.

A simplified preoperative risk assessment tool as a predictor of complications in the surgical management of forearm fractures.

Congiusta D, Amer K, Pooja Suri D, et al.

Journal of clinical orthopaedics and trauma 2021; (14()):121-126 doi:10.1016/j.jcot.2020.07.014.

High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.

Bender L, Somme F, Lhermitte B, et al.

Chinese clinical oncology 2021; (10(3)):26 doi:10.21037/cco-20-226.

Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.

Prat-Acín R, Guarín-Corredor MJ, Galeano-Senabre I, et al.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021; (86()):32-37 doi:10.1016/j.jocn.2021.01.009.

EANO guideline on the diagnosis and management of meningiomas.

Goldbrunner R, Stavrinou P, Jenkinson MD, et al.

Neuro-oncology 2021; (23(11)):1821-1834 doi:10.1093/neuonc/noab150.

Preoperative risk factors associated with new focal neurological deficit and other major adverse events in first-time intracranial meningioma neurosurgery.

Jenkins FS, Vasella F, Padevit L, et al.

Acta neurochirurgica 2021; (163(10)):2871-2879 doi:10.1007/s00701-021-04897-x.

A collision tumor of solitary fibrous tumor/hemangiopericytoma and meningioma: A case report with literature review.

Ashizawa K, Ogura K, Nagase S, et al.

Pathology international 2021; (71(10)):697-706 doi:10.1111/pin.13150.

Association of baseline frailty status and age with postoperative morbidity and mortality following intracranial meningioma resection.

Dicpinigaitis AJ, Kazim SF, Schmidt MH, et al.

Journal of neuro-oncology 2021; (155(1)):45-52 doi:10.1007/s11060-021-03841-4.

Two Birds with One Stone: Skull Base Meningioma and Jugulotympanic Paragangliomas with Somatostatin Receptor Positron Emission Tomography.

Treglia G, Raditchkova M, Giovanella L, et al.

Diagnostics (Basel, Switzerland) 2021; (11(9)) doi:10.3390/diagnostics11091669.

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.

Maas SLN, Stichel D, Hielscher T, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021; (39(34)):3839-3852 doi:10.1200/JCO.21.00784.

Chemotherapy and targeted therapies for meningiomas: what is the evidence?

Graillon T, Tabouret E, Chinot O

Current opinion in neurology 2021; (34(6)):857-867 doi:10.1097/WCO.0000000000001002.

Meningioma during pregnancy: what can influence the management? A case series and review of the literature.

Carbone L, Somma T, Iorio GG, et al.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022; (35(25)):8767-8777 doi:10.1080/14767058.2021.2004585.

Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.

Song D, Xu D, Han H, et al.

Frontiers in oncology 2021; (11()):787962 doi:10.3389/fonc.2021.787962.

Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis.

Kim MS, Chun SW, Dho YS, et al.

Brain tumor pathology 2022; (39(2)):99-110 doi:10.1007/s10014-021-00419-w.

Predictors of postoperative seizure outcome in supratentorial meningioma.

Gadot R, Khan AB, Patel R, et al.

Journal of neurosurgery 2022; (137(2)):515-524 doi:10.3171/2021.9.JNS211738.

Prognostic impact of genetic alterations and methylation classes in meningioma.

Berghoff AS, Hielscher T, Ricken G, et al.

Brain pathology (Zurich, Switzerland) 2022; (32(2)):e12970 doi:10.1111/bpa.12970.

Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.

Brastianos PK, Kim AE, Giobbie-Hurder A, et al.

Nature communications 2022; (13(1)):1325 doi:10.1038/s41467-022-29052-7.

Presentation and management of spinal meningioma and its association with breast carcinoma-case series and systematic review.

Wang D, Sadek AR, Vaseeharan S, et al.

British journal of neurosurgery 2024; (38(6)):1460-1465 doi:10.1080/02688697.2022.2061419.

Are bone erosion and peripheral feeding vessels hallmarks of intracranial solitary fibrous tumor/hemangiopericytoma?

Sugiyama H, Tsutsumi S, Hashizume A, et al.

Radiology case reports 2022; (17(8)):2702-2707 doi:10.1016/j.radcr.2022.04.050.

A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.

Bota DA, Taylor TH, Lomeli N, et al.

Frontiers in oncology 2022; (12()):934638 doi:10.3389/fonc.2022.934638.

Meningioma originating from the oculomotor nerve without dural attachment in a child.

Wang Y, Liu Y, Sun P, et al.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2023; (39(2)):553-556 doi:10.1007/s00381-022-05553-0.

Grade III solitary fibrous tumor/hemangiopericytoma: An enthralling intracranial tumor-A case report and literature review.

Al Armashi AR, Alkrekshi A, Al Zubaidi A, et al.

Radiology case reports 2022; (17(10)):3792-3796 doi:10.1016/j.radcr.2022.07.007.

Acute subdural hematoma associated with disruption of tumor vessels due to rapid growth of falx meningioma: A case report and literature review.

Oyamada K, Ohbuchi H, Nishiyama K, et al.

Surgical neurology international 2022; (13()):495 doi:10.25259/SNI_553_2022.

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy.

Kamogawa M, Shuto T, Matsunaga S

Surgical neurology international 2022; (13()):563 doi:10.25259/SNI_802_2022.

Recent advances in the molecular prognostication of meningiomas.

Wang EJ, Haddad AF, Young JS, et al.

Frontiers in oncology 2022; (12()):910199 doi:10.3389/fonc.2022.910199.

Solitary fibrous tumor of the central nervous system invading and penetrating the skull: A case report.

Lin Q, Zhu J, Zhang X

Oncology letters 2023; (25(2)):81 doi:10.3892/ol.2023.13667.

The experience of living with malignant meningioma.

Maier AD, Nordentoft S, Mathiesen T, Guldager R

Palliative & supportive care 2024; (22(2)):338-346 doi:10.1017/S1478951523000585.

Base MRI Imaging Characteristics of Meningioma Patients to Discuss the WHO Classification of Brain Invasion Otherwise Benign Meningiomas.

Luo X, Jiang H, Liu XJ, et al.

Technology in cancer research & treatment 2023; (22()):15330338231171470 doi:10.1177/15330338231171470.

The joint impacts of sex and race/ethnicity on incidence of grade 1 versus grades 2-3 meningioma across the lifespan.

Walsh KM, Price M, Neff C, et al.

Neuro-oncology advances 2023; (5(Suppl 1)):i5-i12 doi:10.1093/noajnl/vdad020.

Meningioma-Related Epilepsy: A Happy Ending?

Pauletto G, Nilo A, Pez S, et al.

Journal of personalized medicine 2023; (13(7)) doi:10.3390/jpm13071124.

Multidisciplinary approach to anaplastic and metastatic meningioma: A case report and review of the literature.

Ajler P, Davila EZG, Plou P, et al.

Surgical neurology international 2023; (14()):230 doi:10.25259/SNI_222_2023.

Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy.

Yarabarla V, Mylarapu A, Han TJ, et al.

Frontiers in oncology 2023; (13()):1137849 doi:10.3389/fonc.2023.1137849.

A rare case of intra-parenchymal meningioma in a female patient who presented with seizures: A case report.

Duvuru S, Sanker V, Jain S, et al.

Clinical case reports 2023; (11(9)):e7927 doi:10.1002/ccr3.7927.

Peritumoral Edema in Gliomas: A Review of Mechanisms and Management.

Ohmura K, Tomita H, Hara A

Biomedicines 2023; (11(10)) doi:10.3390/biomedicines11102731.

Use of progestogens and the risk of intracranial meningioma: national case-control study.

Roland N, Neumann A, Hoisnard L, et al.

BMJ (Clinical research ed.) 2024; (384()):e078078 doi:10.1136/bmj-2023-078078.

The Recent Management of Vestibular Schwannoma Radiotherapy: A Narrative Review of the Literature.

Brun L, Mom T, Guillemin F, et al.

Journal of clinical medicine 2024; (13(6)) doi:10.3390/jcm13061611.

Surgical treatment of feline intracranial meningiomas: a retrospective study of 26 cases.

Porsmoguer C, Blondel M, Moissonnier PHM

Journal of veterinary science 2024; (25(2)):e25 doi:10.4142/jvs.23207.

Perifocal edema is a risk factor for preoperative seizures in patients with meningioma WHO grade 2 and 3.

Teske N, Teske NC, Greve T, et al.

Acta neurochirurgica 2024; (166(1)):170 doi:10.1007/s00701-024-06057-3.

Prognostic Factors and Outcomes in World Health Organization Grade 1 and Grade 2 Intracranial Meningiomas-5-Year Institutional Experience.

Nadeem M, Goyal-Honavar A, Sravya P, et al.

World neurosurgery 2024; (187()):e331-e339 doi:10.1016/j.wneu.2024.04.082.

Theranostics in Neuroendocrine Tumors.

Mallak N, O'Brien SR, Pryma DA, Mittra E

Cancer journal (Sudbury, Mass.) 2024; (30(3)):185-193 doi:10.1097/PPO.0000000000000723.

Meningioma: Molecular Updates from the 2021 World Health Organization Classification of CNS Tumors and Imaging Correlates.

Soni N, Ora M, Bathla G, et al.

AJNR. American journal of neuroradiology 2025; (46(2)):240-250 doi:10.3174/ajnr.A8368.

Lifestyle and metabolic factors affect risk for meningioma in women: a prospective population-based study (The Cohort of Norway).

Gheorghiu A, Brunborg C, Johannesen TB, et al.

Frontiers in oncology 2024; (14()):1428142 doi:10.3389/fonc.2024.1428142.

cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.

Sahm F, Aldape KD, Brastianos PK, et al.

Neuro-oncology 2025; (27(2)):319-330 doi:10.1093/neuonc/noae170.

A Radiomics Model for the Differentiation of Intracranial Solitary Fibrous Tumor/Hemangiopericytoma and Meningioma Based on Multiparametric Magnetic Resonance Imaging.

Xiong H, Yin P, Luo W, et al.

Neurology India 2024; (72(4)):779-783 doi:10.4103/neurol-india.NI_213_20.

Preoperative frailty and postoperative complications after non-cardiac surgery: a systematic review.

Becerra-Bolaños Á, Hernández-Aguiar Y, Rodríguez-Pérez A

The Journal of international medical research 2024; (52(9)):3000605241274553 doi:10.1177/03000605241274553.

Quality of life in patients with skull base meningiomas treated with microsurgery: a prospective observational study.

Pradhan R, Misra BK, Hosmann A

Acta neurochirurgica 2024; (166(1)):416 doi:10.1007/s00701-024-06291-9.

Health-related quality of life in surgically treated asymptomatic meningioma patients: A population-based matched cohort study.

Näslund O, Jakobsson S, Thurin E, et al.

Neuro-oncology practice 2024; (11(6)):723-732 doi:10.1093/nop/npae047.

Management of intracranial meningioma: Outcome analysis and clinico radiological profile of 172 patients.

Varshney A, Jaiswal S, Bajaj A, et al.

Surgical neurology international 2024; (15()):464 doi:10.25259/SNI_556_2024.

Exploring the genetic correlation and causal relationships between breast cancer and meningioma using bidirectional Mendelian randomization.

Ding L, Chen B, Zhou Z, et al.

Scientific reports 2025; (15(1)):4271 doi:10.1038/s41598-025-88829-0.

A novel rotation and scale-invariant deep learning framework leveraging conical transformers for precise differentiation between meningioma and solitary fibrous tumor.

Azam MT, Balaha HM, Mistry A, et al.

Journal of pathology informatics 2025; (17()):100422 doi:10.1016/j.jpi.2025.100422.

Perioperative Seizures and Quality of Life in Falx and Convexity Meningiomas: Key Factors of Patient Outcomes.

Basaran AE, Vychopen M, Güresir E, Wach J

Cancers 2025; (17(7)) doi:10.3390/cancers17071174.

Meningiomas-Related Epilepsy After Surgery.

Battista F, Cultrera G, Aldea CA, et al.

Cancers 2025; (17(9)) doi:10.3390/cancers17091523.

An evidence-based framework for postoperative surveillance of meningioma.

Owusu-Adjei B, Lim JC, Hou CC, et al.

Neuro-oncology practice 2025; (12(3)):478-488 doi:10.1093/nop/npae117.

Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study.

Roland N, Kolla E, Baricault B, et al.

BMJ (Clinical research ed.) 2025; (389()):e083981 doi:10.1136/bmj-2024-083981.

Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis.

Muoio B, Iacovitti CM, Bosetti DG, et al.

Cancers 2025; (17(12)) doi:10.3390/cancers17122039.

Meningioma in users of progestogen contraceptives: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS).

Woods RH

European journal of clinical pharmacology 2025; (81(11)):1659-1668 doi:10.1007/s00228-025-03900-z.

Determinants of geographic variation in the incidence of adult nonmalignant meningioma in the United States, 2010-2019.

Withrow DR, Boyle J, Linet MS, et al.

Cancer 2025; (131(18)):e70042 doi:10.1002/cncr.70042.

A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory Meningiomas.

Nguyen DC, Nader C, Bélanger K, et al.

Current oncology (Toronto, Ont.) 2025; (32(9)) doi:10.3390/curroncol32090516.

Peritumoral MRI findings and brain herniations in epileptic dogs with prosencephalic brain tumors: a multicentre retrospective study.

Tabbì M, Fugazzotto D, Caterino C, et al.

Frontiers in veterinary science 2025; (12()):1661131 doi:10.3389/fvets.2025.1661131.

Racial or Ethnic Disparities in Incidence, Treatment, and Prognosis of Adult Intracranial Meningiomas.

Li C, Yuan Q, Zhang Z, et al.

Journal of racial and ethnic health disparities 2025; doi:10.1007/s40615-025-02650-z.

Recurrence of Atypical Meningioma: A Case Report.

Paul A, Johnson S, Patel SM

Cureus 2025; (17(10)):e94686 doi:10.7759/cureus.94686.

Subsequent Meningiomas Among Survivors of Childhood Cancer.

Bowers DC, Cooney T, Chen Y, et al.

JAMA network open 2025; (8(12)):e2548715 doi:10.1001/jamanetworkopen.2025.48715.

Progestogen use and the risk of intracranial meningioma: a systematic review and meta-analysis.

Hudelist B, Roux A, Huet-Mignaton E, et al.

EClinicalMedicine 2026; (92()):103791 doi:10.1016/j.eclinm.2026.103791.